Статья

Hydroxychloroquine: The story of one drug during the COVID-19 pandemic

E. Nikonov, M. Zhuravleva, M. Zharova, M. Gorelov,
2020

The new coronavirus (SARS-CoV-2) poses a serious threat to public health worldwide. From the moment of its finding to the present, the incidence of new cases is only increasing. So far, no drugs were proven to have antiviral activity in clinical practice. Many drugs have already gone a path from in vitro studies to randomized clinical trials in vivo. Objective. To review the literature on the use of hydroxychloroquine for the prevention and treatment of new coronavirus infection (COVID-19) for the period from the date of use until June 2020.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2020-01-01

Метаданные

Об авторах
  • E. Nikonov
    Pirogov Russian National Research Medical University (RNRMU)
  • M. Zhuravleva
    Ministry of Health of Russian Federation, Sechenov First Moscow State Medical University
  • M. Zharova
    Pirogov Russian National Research Medical University (RNRMU), State Budgetary Institution "Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department"
  • M. Gorelov
    Pirogov Russian National Research Medical University (RNRMU)
Название журнала
  • Profilakticheskaya Meditsina
Том
  • 23
Выпуск
  • 8
Страницы
  • 74-82
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus